EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LEAP2 modulates β-adrenergic triggered cardiac responses and provokes antihypertensive effects

Sixta Isabel Atencio Berrio, Jhulle Horrane Carvalho, João Batista Dutra, Marcos Eliezeck, Sergio Scalzo, Juliana Vila Verde Ribeiro, Michelle Mendanha Mendonça, Rodrigo Mello Gomes, Gustavo Rodrigues Pedrino, Eduardo Colombari, Daniel Castrogiovanni, Sisti Maria Milagros und 8 weitere

Life Sciences · 2026

DOI: 10.1016/j.lfs.2026.124243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2026. Verfasst von Sixta Isabel Atencio Berrio und 19 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciências Fisiológicas, Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiânia, GO, Brazil. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Heart, Receptors, Adrenergic, beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Research Support of Goiás State, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Receptors for orexigenic hormones are broadly expressed in different tissues. Growth hormone secretagogue receptor (GHSR) is the receptor for the gastric peptide hormone ghrelin, although it further displays an intrinsic ligand-independent activity. The liver-expressed antimicrobial peptide 2 (LEAP2) has been recently identified as GHSR endogenous antagonist and inverse agonist. To understand LEAP2 effects on cardiac performance, we assessed (in-vivo) Wistar (WT) and spontaneously hypertensive rats (SHR), isolated hearts (ex-vivo) and cardiomyocytes (in-vitro). Intravenous LEAP2 injection reduced arterial pressure, with a greater effect in SHR. LEAP2 also reduced cardiac inotropism in both WT and SHR, whereas a negative chronotropy was observed only in SHR. LEAP2 perfusion reduced intraventricular pressure in isolated SHR hearts and attenuated the responses to isoproterenol on coronary flow, whereas responses to acetylcholine were almost unaffected by LEAP2. Fluorescent LEAP2 or ghrelin labeled cardiomyocytes. LEAP2 or the synthetic inverse agonist PF04628935 produced an equipotent reduction in maximum contraction speed, reduced cardiomyocyte shortening area, and attenuated the responses to isoproterenol, but not to acetylcholine. Plasma levels of ghrelin and LEAP2 were not different between strains, but higher GHSR levels were found in SHR hearts. In conclusion, LEAP2 exerted marked cardiovascular effects, reducing arterial pressure and left ventricular systolic performance in both WT and SHR, with a greater impact in hypertensive animals. However, GHSR involvement in SHR cardiac abnormalities is unrelated to the circulating levels of its endogenous ligands and instead seems to depend on altered cardiac GHSR expression and function. The cardiac LEAP2 interaction with β-adrenergic receptors reveals an important cardioprotective potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertensionHeartReceptors, Adrenergic, betaAnimalsRats, Inbred SHRRats, WistarRatsMyocytes, CardiacMaleMyocardial ContractionGhrelinReceptors, GhrelinBlood Pressure

Stichwörter der Autor:innen

Cardiac physiologyGHSRGhrelinHypertensionLEAP2β-Adrenergic

Substanzen

Antihypertensive AgentsGhrelinReceptors, GhrelinReceptors, Adrenergic, beta

Autor:innen und Institutionen

  • Departamento de Ciências Fisiológicas, Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiânia, GO, Brazil.
  • Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, MG, Brazil.
  • Departamento de Ciências Fisiológicas, Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiânia, GO, Brazil; Departamento de Fisiologia de Patologia, Faculdade de Odontologia, Universidade Estadual de Sã…
  • Departamento de Fisiologia de Patologia, Faculdade de Odontologia, Universidade Estadual de São Paulo, Araraquara, SP, Brazil.
  • Instituto Multidisciplinario de Biología Celular (Universidad Nacional de La Plata (UNLP) - Comisión de Investigaciones Científicas de la Provincia de Buenos Aires (CIC-PBA) - Consejo Nacional de Investigaciones Científ…
  • Instituto de Investigaciones Bioquímicas de La Plata, Universidad Nacional de La Plata (UNLP), La Plata, Argentina.

Förderung

  • Foundation for Research Support of Goiás State
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Berrio, S. I. A., Carvalho, J. H., Dutra, J. B., Eliezeck, M., Scalzo, S., Ribeiro, J. V. V., Mendonça, M. M., Gomes, R. M., Pedrino, G. R., Colombari, E., Castrogiovanni, D., Milagros, S. M., Racioppi, M. F., Petroff, M. V., Cantel, S., Fehrentz, J. A., Guatimosim, S., Perelló, M., de Castro, C. H., & Xavier, C. H. (2026). LEAP2 modulates β-adrenergic triggered cardiac responses and provokes antihypertensive effects. Life Sciences. https://doi.org/10.1016/j.lfs.2026.124243

Vancouver

Berrio SIA, Carvalho JH, Dutra JB, Eliezeck M, Scalzo S, Ribeiro JVV, et al. LEAP2 modulates β-adrenergic triggered cardiac responses and provokes antihypertensive effects. Life Sciences. 2026. doi:10.1016/j.lfs.2026.124243

BibTeX
@article{Berrio2026,
  author = {Berrio, Sixta Isabel Atencio and Carvalho, Jhulle Horrane and Dutra, João Batista and Eliezeck, Marcos and Scalzo, Sergio and Ribeiro, Juliana Vila Verde and Mendonça, Michelle Mendanha and Gomes, Rodrigo Mello and Pedrino, Gustavo Rodrigues and Colombari, Eduardo and Castrogiovanni, Daniel and Milagros, Sisti Maria and Racioppi, Maria Florencia and Petroff, Martin Vila and Cantel, Sonia and Fehrentz, Jean-Alain and Guatimosim, Silvia and Perelló, Mario and de Castro, Carlos Henrique and Xavier, Carlos Henrique},
  title = {LEAP2 modulates β-adrenergic triggered cardiac responses and provokes antihypertensive effects},
  journal = {Life Sciences},
  year = {2026},
  doi = {10.1016/j.lfs.2026.124243}
}
Kostenlos starten →